Frontlight ResearchEarly access
Trial site
Komaromi Selye Janos Korhaz
- 10running trials
- 9closed trials
The trials here
What the 19 trials at this site are about, from their registry records.
- Conditions
- Obesity8 trials
- Type 2 diabetes8 trials
- Heart failure3 trials
- Atrial fibrillation2 trials
- Stroke2 trials
- Asthma1 trial
- Chronic kidney disease1 trial
- COPD1 trial
- Coronary artery disease1 trial
- High blood pressure1 trial
- Type 1 diabetes1 trial
- Phase
- Phase 318 trials
- Phase 21 trial
- Status
- Completed9 trials
- Active, not recruiting6 trials
- Recruiting4 trials
- Lead sponsor
- Novo Nordisk A/S7 trials
- Amgen4 trials
- Amgen Inc.2 trials
- AstraZeneca2 trials
- Bayer AG1 trial
- and 3 more
Running trials
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Obesity3 recruiting
- Heart failure2 recruiting
- Type 2 diabetes2 recruiting
- High blood pressure1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026